Zhende Medical Co., Ltd.

XSSC:603301 Stock Report

Market Cap: CN¥6.2b

Zhende Medical Future Growth

Future criteria checks 4/6

Zhende Medical is forecast to grow earnings and revenue by 36.9% and 18.3% per annum respectively. EPS is expected to grow by 37% per annum. Return on equity is forecast to be 9.5% in 3 years.

Key information

36.9%

Earnings growth rate

37.0%

EPS growth rate

Medical Equipment earnings growth26.5%
Revenue growth rate18.3%
Future return on equity9.5%
Analyst coverage

Low

Last updated31 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:603301 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20266,1976281617492
12/31/20255,2865171646902
12/31/20244,4944072268452
9/30/20244,043205-375349N/A
6/30/20243,863122-226439N/A
3/31/20243,79012529684N/A
12/31/20234,127198-147452N/A
9/30/20235,1495256951,207N/A
6/30/20235,6776467111,287N/A
3/31/20236,173714302922N/A
12/31/20226,1386804921,246N/A
9/30/20225,426568-295605N/A
6/30/20224,946489-222564N/A
3/31/20224,362454-39706N/A
12/31/20215,092596122818N/A
9/30/20216,14593488962N/A
6/30/20219,4911,9391581,183N/A
3/31/202111,6842,7181,9843,153N/A
12/31/202010,3992,5492,0283,121N/A
9/30/20208,6992,1602,0092,773N/A
6/30/20204,9251,0851,8942,447N/A
3/31/20202,243212110437N/A
12/31/20191,868157-76198N/A
9/30/20191,686140-43187N/A
6/30/20191,526138-139153N/A
3/31/20191,483141-259-8N/A
12/31/20181,429130-20620N/A
9/30/20181,388135-12719N/A
6/30/20181,360128N/A12N/A
3/31/20181,294119N/A155N/A
12/31/20171,306122N/A191N/A
12/31/20161,03583N/A139N/A
12/31/20151,02179N/A143N/A
12/31/201498722N/A84N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603301's forecast earnings growth (36.9% per year) is above the savings rate (2.8%).

Earnings vs Market: 603301's earnings (36.9% per year) are forecast to grow faster than the CN market (26.2% per year).

High Growth Earnings: 603301's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 603301's revenue (18.3% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 603301's revenue (18.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 603301's Return on Equity is forecast to be low in 3 years time (9.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y